Cargando…
Viral Particle-Mediated SAMHD1 Depletion Sensitizes Refractory Glioblastoma to DNA-Damaging Therapeutics by Impairing Homologous Recombination
SIMPLE SUMMARY: Glioblastoma (GBM) is a lethal and common primary brain tumor that accounts for about 50% of all diagnosed malignant gliomas. Despite aggressive standard-of-care treatment of surgical resection followed by γ-irradiation (IR) and DNA alkylating agent temozolomide (TMZ), the average po...
Autores principales: | Daddacha, Waaqo, Monroe, Dominique, Carver, Kristen, Usoro, Edidiong R., Alptekin, Ahmet, Xu, Hongyan, Osuka, Satoru, Arbab, Ali S., Sakamuro, Daitoku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497202/ https://www.ncbi.nlm.nih.gov/pubmed/36139652 http://dx.doi.org/10.3390/cancers14184490 |
Ejemplares similares
-
Restriction of diverse retroviruses by SAMHD1
por: Gramberg, Thomas, et al.
Publicado: (2013) -
Restoration of tumor suppressor functions by small-molecule inhibitors
por: Pyndiah, Slovénie, et al.
Publicado: (2015) -
SAMHD1 deacetylation by SIRT1 promotes DNA end resection by facilitating DNA binding at double-strand breaks
por: Kapoor-Vazirani, Priya, et al.
Publicado: (2022) -
The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance
por: Kumari, Alpana, et al.
Publicado: (2017) -
New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors
por: Folk, Watson P., et al.
Publicado: (2021)